Clinical Trials Browser

Multiple Myeloma × Bendamustine Hydrochloride × 90 days × Clear all

NCT04674813 2026-02-09

A Study of CC-95266 in Participants With Relapsed and/or Refractory Multiple Myeloma

Phase 1 Completed

Multiple Myeloma